3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Carcinoma, Basal Cell
6
Lung Neoplasms
4
Skin Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasms
2
Keratosis, Actinic
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Telangiectasis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rosacea
1
Recurrent respiratory papillomatosis
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Intraductal Neoplasms
1
Non-melanoma Skin Cancer
1
Nevus, Pigmented
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Mouth Diseases
1
Mixed Tumor, Malignant
1
Mesothelioma, Malignant
1
Melanoma
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Kidney Neoplasms
1
Interventions
Cyclophosphamide
72
fludarabine
65
Tacrolimus
43
fludarabine phosphate
40
Whole-Body Irradiation
37
Mycophenolic Acid
35
Busulfan
32
Melphalan
28
Antilymphocyte Serum
23
thymoglobulin
22
Thiotepa
20
Methotrexate
20
Standard of Care
19
Stem Cell Transplantation
17
Practice Guidelines as Topic
17
Granulocyte Colony-Stimulating Factor
17
Rituximab
15
Surveys and Questionnaires
12
Sirolimus
12
Filgrastim
12
Interviews as Topic
11
Cyclosporine
11
Blood Specimen Collection
11
Peripheral Blood Stem Cell Transplantation
10
Exercise
10
venetoclax
9
Mesna
9
Cytarabine
9
Bortezomib
9
Hematopoietic Stem Cell Transplantation
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hematologic Neoplasms
×
Tomography, Optical Coherence
×
Clear all
NCT04188912
2025-10-02
CATCH
Fred Hutchinson Cancer Center
Completed
267 enrolled